Identification of a p53-dependent Negative Response Element in the bcl-2 Gene

Cancer Research

Volumn 54, Issue 12, 1994, Pages 3131-3135

  Miyashita, Toshiyuki ^a   Harigai, Masayoshi ^a   Hanada, Motoi ^a   Reed, John C ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; DNA FRAGMENT;

ARTICLE; CANCER CELL CULTURE; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENE STRUCTURE; HUMAN; HUMAN CELL; LUNG CANCER; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SILENCER GENE; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; COMPARATIVE STUDY; DOWN-REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GENES, REGULATOR; GENES, REPORTER; HUMAN; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROTEIN P53; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SIMIAN VIRUS 40; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSLATION, GENETIC;

EID: 0028292480     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C.C. p. 3 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
2. Vogelstein, B., and Kinzler, K.W. p. 3 function and dysfunction. Cell, 70: 523-526, 1992.
3. Malkin, D., Li, F.P., Strong, L.C., Fraumeni, J.F., Nelson, C.E., Kim, D.H., Kassel, J., Gryka, M.A., Bischoff, F.Z., Tainsky, M.A., and Friend, S.H. Germ line p. 3 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (Washington DC), 250: 1233-1238, 1990.
4. Mietz, J.A., Unger, T., Huibregtse, J.M., and Howley, P.M. The transcriptional activation function of wild-type p. 3 is inhibited by SV40 large T antigen and by HPV-16 E6 oncoprotein. EMBO J., 11: 5013-5020, 1992.
5. Dutta, A., Ruppert, J.M., Aster, J.C., and Winchester, E. Inhibition of DNA replication factor RPA by p. 3. Nature (Lond.), 365: 79-82, 1993.
6. Kern, S.E., Pietenpol, J.A., Thiagalingam, S., Seymour, A., Kinzler, K.W., and Vogelstein, B. Oncogenic forms of p. 3 inhibit p. 3-regulated gene expression. Science (Washington DC), 256: 827-830, 1992.
7. Scharer, E., and Iggo, R. Mammalian p. 3 can function as a transcription factor in yeast. Nucleic Acids Res., 20: 1539-1545, 1992.
8. Unger, T., Nau, M.M., Segal, S., and Minna, J.D. Functional domains of wild-type and mutant p. 3 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression. EMBO J., 11: 1383-1390, 1992.
9. Ginsberg, D., Mechta, F., Yaniv, M., and Oren, M. Wild-type p. 3 can down-modulate the activity of various promoters. Proc. Natl. Acad. Sci. USA, 88: 9979-9983, 1991.
10. Chin, K.V., Ueda, K., Pastan, I., and Gottesman, M.M. Modulation of activity of the promoter of the human MDR1 gene by ras and p. 3. Science (Washington DC), 255: 459-462, 1992.
11. Mack, D.H., Vartikar, J., Pipas, J.M., and Laimins, L.A. Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p. 3. Nature (Lond.), 363, 281-283, 1993.
12. Liu, X., Miller, C.W., Koeffler, P.H., and Berk, A.J. The p. 3 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p. 3 domain inhibits transcription. Mol. Cell. Biol., 13: 3291-3300, 1993.
13. Miyashita, T., Krajewski, S., Krajewska, M., Wang, H.G., Lin, H.K., Hoffman, B., Lieberman, D., and Reed, J.C. Tumor suppressor p. 3 is a regulator of bcl-2 and box gene expression in vitro and in vivo. Oncogene, in press, 1994.
14. Reed, J.C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol., 124: 1-6, 1994.
15. Tsujimoto, Y. Bashir, M.M., Givol, I., Cossman, J., Jaffe, E., and Croce, C.M. DNA rearrangements in human follicular lymphoma can involve the 5′ or the 3′ region of the bcl-2 gene. Proc. Natl. Acad. Sci. USA, 84: 1329-1331, 1987.
16. Fukamizu, A., Tanimoto, K., Uehara, S., Seo, M.S., Handa, S., Sagara, M., Takahashi, S., Imai, T., and Murakami, K. Regulation of human renin and angiotensinogen genes. Biomed. Biochim. Acta, 50: 4-6, 1991.
17. Takahashi, T., Nau, M.M., Chiba, I., Birrer, M.J., Rosenberg, R.K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A.F., and Minna, J.D. p. 3: a frequent target for genetic abnormalities in lung cancer. Science (Washington DC), 246: 491-494, 1989.
18. MacGregor, G.R., and Caskey, C.T. Construction of plasmids that express E. coli β-galactosidase in mammalian cells. Nucleic Acids Res., 17: 2365, 1989.
19. Pfahl, M., Tzukerman, M., Zhang, X., Lehmann, J.M., Hermann, T., Wills, K.N., and Graupner, G. Nuclear retinoic acid receptors: cloning, analysis, and function. Methods Enzymol., 189: 256-270, 1990.
20. Seto, M., Jaeger, V., Hockett, R., Graninger, W., Bennett, S., Goldman, P., and Korsmeyer, S.J. Alternative promoters and exons, somatic mutation, and deregulation of Bcl-2/Ig fusion gene in lymphoma. EMBO J., 7: 123-131, 1988.
21. Young, R.L., and Korsmeyer, S.J. A negative regulatory element in the bcl-2 5′-untranslated region inhibits expression from an upstream promoter. Mol. Cell. Biol., 13: 3686-3697, 1993.
22. Tsujimoto, Y., Cossman, J., Jaffe, B., and Croce, C.M. Involvement of the bcl-2 gene in human follicular lymphoma. Science (Washington DC), 228: 1440-1443, 1985.
23. Reed, J.C., Tsujimoto, Y., Epstein, S., Cuddy, M., Slabiak, T., Nowel, P., and Croce, C.M. Regulation of bcl-2 gene expression in lymphoid cell lines containing t(14;18) or normal #18 chromosomes. Oncogene Res., 4: 271-282, 1989.
24. Reed, J.C., Meister, L., Tanaka, S., Cuddy, M., Yum, S., Geyer, C., and Pleasure, D. Differential expression of the bcl-2 proto-oncogene in neuroblastomas and other human neural tumors. Cancer Res., 51: 6529-6538, 1991.
25. McDonnell, T., Troncoso, P., Brisbary, S., Logothetis, C., Chung, L, Hsieh, J., Tu, S., and Campbell, M. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res., 52: 6940-6944, 1992.
26. Pezzella, F., Turley, H., Kuzu, I., Tungekar, M., Dunnil, M., Pierce, C., Harris, A., Gatter, K., and Mason, D. bcl-2 protein in non-small-cell lung carcinoma. N. Engl. J. Med., 329: 690-694, 1993.
27. Lu, Q.L., Lucas, E.S., and Thomas, J.A. bcl-2 proto-concogene expression in Epstein-Barr virus-associated nasopharyngeal carcinoma. Int. J. Cancer, 53: 29-35, 1993.
28. Leek, R.D., Kaklamanis, L., Pezzella, F., Gatter, K.C., and Harris, A.L. bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. Br. J. Cancer, 69: 135-139, 1994.
29. Haldar, S., Negrini, M., Monne, M., Sabbioni, S., and Croce, C.M. Down-regulation of bcl-2 by p. 3 in breast cancer. Cancer Res., 54: 2095-2097, 1994.
30. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A., and Oren, M. Wild-type p. 3 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (Lond.), 352: 345-347, 1991.
31. Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordat, B., and Costa, J. Induction of apoptosis by wild-type p. 3 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA, 89: 4495-4499, 1992.
32. Lowe, S.W., Ruley, H.E., Jacks, T., and Housman, D.E. p. 3-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993.
33. Lowe, S.W., Schmitt, E.M., Smith, S.W., Osborne, B.A., and Jacks, T. p. 3 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847-849, 1993.
34. Clarke, A.R., Purdie, C.A., Harrison, D.J., Morris, R.G., Bird, C.C., Hooper, M.L., and Wyllie, A.H. Thymocyte apoptosis induced by p. 3-dependent and independent pathways. Nature (Lond.), 362: 849-852, 1993.